NCT03633942 (LMA) is a clinical trial of LMA Supreme in Airway Obstruction, sponsored by Laser Spine Institute.

Who is sponsoring NCT03633942?

NCT03633942 is sponsored by Laser Spine Institute.

What drugs are being tested in NCT03633942?

Interventions in NCT03633942: LMA Supreme.

What condition does NCT03633942 study?

NCT03633942 studies Airway Obstruction.

Is NCT03633942 still recruiting?

NCT03633942 is currently status unknown. Last updated 24 August 2018.

Last reviewed 2018-08-24 · How we verify

NCT03633942: LMA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Efficacy of the LMA Supreme When Inserted With Patients in the Prone Position

Status unknown Last updated 24 August 2018

What this trial tests

trial testing LMA Supreme in Airway Obstruction in 1,000 participants. Status unknown.

Timeline

27 July 2018

Primary endpoint
27 July 2019

27 July 2020

Quick facts

Lead sponsor	Laser Spine Institute
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	27 July 2018
Primary completion	27 July 2019
Estimated completion	27 July 2020
Sites	1 location across United States

Drugs / interventions tested

LMA Supreme

Conditions studied

Airway Obstruction — all drugs for Airway Obstruction →

Sponsor

Laser Spine Institute

Who can join

Adults 18 to 70, any sex, with Airway Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a non-randomized, observational, non-comparative prospective study to evaluate the safety, efficacy and performance of the LMA Supreme laryngeal mask airway when used according to the device's Instructions for Use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of LMA Supreme

Trials testing the same drug.

NCT06545903 — Supraglottic Airways for Entrapped Trauma Patients · NA · completed
NCT06245668 — SaCoVLM™ Video Laryngeal Mask Versus LMA Supreme · NA · completed
NCT03984032 — LMA Protector Cuff Pilot vs LMA Supreme Among Anaesthetised, Non-Paralysed Patients · NA · completed
NCT03108391 — A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients · NA · unknown

Other recruiting trials for Airway Obstruction

Currently open trials in the same condition.

NCT05974488 — The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE · NA · recruiting
NCT03049202 — BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03633942 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laser Spine Institute
Last refreshed: 24 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03633942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing